Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

Galapagos Delivers Validated Oncology Targets to Janssen

By Pharmaceutical Processing | April 20, 2011

Galapagos
NV announced today that its
BioFocus service division has delivered a panel of validated oncology targets
in its collaboration with Janssen Research & Development, a division of
Janssen Pharmaceutica N.V. (Janssen). Per the agreement, Janssen retains full
rights to discover, develop and commercialize novel medicines on these targets.

In January 2008, BioFocus entered into a fee-for-service
target discovery collaboration with Janssen, under which BioFocus developed
assays in cancer cells, and discovered and validated novel targets. In January
2010, BioFocus received a target acceptance payment from Janssen for
identifying and validating drug targets. BioFocus has now confirmed the
activity of a panel of targets across several key pathways in oncology, per
contractually defined criteria. BioFocus may receive success-based payments
should certain downstream criteria be reached by Janssen.

“We continue to see strong demand for our target
discovery capabilities and this collaboration is an example of how we deliver
novelty to pharmaceutical pipelines,” said Onno van de Stolpe, Chief
Executive Officer of Galapagos.

 

Related Articles Read More >

This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
sherwin-williams-pharma-facility (1)
Sherwin-Williams expands flooring solutions for pharma facilities
PHARMAP 2025: Pharma leaders converge in Berlin for fifth anniversary summit
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE